IVC Filter Lawsuit Filings Draw Public Concern Over Statements Of IVC Filter Removal Doctor During NBC Report

April 29, 2016 – – TheProductLawyers.com reports on a news segment released by NBC which was a follow-up to a previous story. The follow-up was conducted in order to further investigate the reasons that IVC filter device manufacturer C.R. Bard has been able to continue to market their filters, even after reports regarding concerning patient suffered complications quickly followed the filter’s FDA approval. NBC noted that the information they had collected from confidential records included both a memo and a study conducted on the medical devices, and had first aired on December 31, 2015.

The report further investigated a topic that is currently alarming for many, as lawsuits referencing IVC filters have now been filed in Canada and the United States. Plaintiffs who have filed suit against various manufacturers of IVC filters similarly claim that the devices are defectively designed and are therefore dangerous, making them able to break loose from their original insertion points and travel within the body becoming lodged in other locations where they could cause additional and serious health complications.

NBC’s report detailed information showing that manufacturer C.R. Bard had concerns over possible product failures within the GC series filters, and that these worries were expressed as early as four months after the filters were given FDA approval. Despite the noted concerns, the filters were left on the market for public sale. Perhaps most concerning, NBC interviewed Dr. William Kuo, an IVC filter removal specialist, who commented, “The number of complications, the frequency of severe failures makes it obvious that it was never safe to be implanted.” The Doctor also used the opportunity to directly address the actions of IVC filter manufacturers, stating that they are not able to be trusted to act within the best interests of patients.

This alarming information and the details uncovered by NBC’s investigation are quite concerning for patients currently implanted with various brands of IVC filters. The filters are used among patients who are deemed at increased risk for blood clots, and are intended to capture and hold blood clots until they dissipate, preventing them from traveling toward the heart and lungs. The filters are meant to be used temporarily, and then removed from the inferior vena cava veins of patients after blood clot risks have subsided.

The attorneys of Banville Law are also concerned by this new information, and are currently working to help other patients who feel that they have been or are being harmed by IVC filters. They want to help ensure that all affected parties will be provided an opportunity to fully evaluate their legal rights in the matter, as these individuals could be entitled to significant compensation. To assist those interested in fully evaluating their legal options, the attorneys of Banville Law are now offering free legal consultations for qualified parties.

To request additional IVC lawsuit information, or to ask questions, please contact the attorneys of Banville Law by calling 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009687